AustralieFrV1, Main, Exploration, bibRecord, 000086

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials.

Identifieur interne : 000086 ( Main/Exploration ); précédent : 000085; suivant : 000087

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials.

Auteurs : Val Gebski [Australie] ; Emma Gibbs [Australie] ; Mihir Gandhi [Singapour] ; Gilles Chatellier [France] ; Aurelia Dinut [France] ; Helena Pereira [France] ; Pierce Kh Chow [Singapour] ; Valérie Vilgrain [France]

Source :

JMIR research protocols [ 1929-0748 ] ; 2017.

RBID : pubmed:28202430

Abstract

Untreated advanced hepatocellular carcinoma (HCC) has an overall poor prognosis. Currently there are 2 ongoing prospective randomized controlled trials that are evaluating the efficacy and safety of sorafenib and selective internal radiation therapy (SIRT) with yttrium-90 resin microspheres in patients with advanced HCC. The SorAfenib versus Radioembolisation in Advanced Hepatocellular carcinoma (SARAH; 459 patients) trial is being performed in Europe and the SIRt VErsus SorafeNIB (SIRveNIB; 360 patients) trial in the Asia Pacific region. Prospectively combining the results, these trials will not only allow for increased precision to estimate efficacy (in terms of survival), but will also provide increased statistical power for subgroup analyses.

DOI: 10.2196/resprot.7016
PubMed: 28202430

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials.</title>
<author><name sortKey="Gebski, Val" sort="Gebski, Val" uniqKey="Gebski V" first="Val" last="Gebski">Val Gebski</name>
<affiliation wicri:level="1"><nlm:affiliation>NHMRC Clinical Trials Centre, University Sydney, Camperdown, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>NHMRC Clinical Trials Centre, University Sydney, Camperdown</wicri:regionArea>
<wicri:noRegion>Camperdown</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gibbs, Emma" sort="Gibbs, Emma" uniqKey="Gibbs E" first="Emma" last="Gibbs">Emma Gibbs</name>
<affiliation wicri:level="4"><nlm:affiliation>NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>NHMRC Clinical Trials Centre, University of Sydney, Camperdown</wicri:regionArea>
<orgName type="university">Université de Sydney</orgName>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gandhi, Mihir" sort="Gandhi, Mihir" uniqKey="Gandhi M" first="Mihir" last="Gandhi">Mihir Gandhi</name>
<affiliation wicri:level="1"><nlm:affiliation>Biostatistics, Singapore Clinical Research Institute, Singapore, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>Biostatistics, Singapore Clinical Research Institute, Singapore</wicri:regionArea>
<wicri:noRegion>Singapore</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chatellier, Gilles" sort="Chatellier, Gilles" uniqKey="Chatellier G" first="Gilles" last="Chatellier">Gilles Chatellier</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dinut, Aurelia" sort="Dinut, Aurelia" uniqKey="Dinut A" first="Aurelia" last="Dinut">Aurelia Dinut</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pereira, Helena" sort="Pereira, Helena" uniqKey="Pereira H" first="Helena" last="Pereira">Helena Pereira</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chow, Pierce Kh" sort="Chow, Pierce Kh" uniqKey="Chow P" first="Pierce Kh" last="Chow">Pierce Kh Chow</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>Division of Surgical Oncology, National Cancer Centre Singapore, Singapore</wicri:regionArea>
<wicri:noRegion>Singapore</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vilgrain, Valerie" sort="Vilgrain, Valerie" uniqKey="Vilgrain V" first="Valérie" last="Vilgrain">Valérie Vilgrain</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Radiology, Assistance Publique, Hôpitaux de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiology, Assistance Publique, Hôpitaux de Paris, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28202430</idno>
<idno type="pmid">28202430</idno>
<idno type="doi">10.2196/resprot.7016</idno>
<idno type="wicri:Area/PubMed/Corpus">001063</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001063</idno>
<idno type="wicri:Area/PubMed/Curation">001060</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001060</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001060</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001060</idno>
<idno type="wicri:Area/Ncbi/Merge">004324</idno>
<idno type="wicri:Area/Ncbi/Curation">004324</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004324</idno>
<idno type="wicri:doubleKey">1929-0748:2017:Gebski V:vespro:an:individual</idno>
<idno type="wicri:Area/Main/Merge">000081</idno>
<idno type="wicri:Area/Main/Curation">000086</idno>
<idno type="wicri:Area/Main/Exploration">000086</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials.</title>
<author><name sortKey="Gebski, Val" sort="Gebski, Val" uniqKey="Gebski V" first="Val" last="Gebski">Val Gebski</name>
<affiliation wicri:level="1"><nlm:affiliation>NHMRC Clinical Trials Centre, University Sydney, Camperdown, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>NHMRC Clinical Trials Centre, University Sydney, Camperdown</wicri:regionArea>
<wicri:noRegion>Camperdown</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gibbs, Emma" sort="Gibbs, Emma" uniqKey="Gibbs E" first="Emma" last="Gibbs">Emma Gibbs</name>
<affiliation wicri:level="4"><nlm:affiliation>NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>NHMRC Clinical Trials Centre, University of Sydney, Camperdown</wicri:regionArea>
<orgName type="university">Université de Sydney</orgName>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gandhi, Mihir" sort="Gandhi, Mihir" uniqKey="Gandhi M" first="Mihir" last="Gandhi">Mihir Gandhi</name>
<affiliation wicri:level="1"><nlm:affiliation>Biostatistics, Singapore Clinical Research Institute, Singapore, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>Biostatistics, Singapore Clinical Research Institute, Singapore</wicri:regionArea>
<wicri:noRegion>Singapore</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chatellier, Gilles" sort="Chatellier, Gilles" uniqKey="Chatellier G" first="Gilles" last="Chatellier">Gilles Chatellier</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dinut, Aurelia" sort="Dinut, Aurelia" uniqKey="Dinut A" first="Aurelia" last="Dinut">Aurelia Dinut</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pereira, Helena" sort="Pereira, Helena" uniqKey="Pereira H" first="Helena" last="Pereira">Helena Pereira</name>
<affiliation wicri:level="3"><nlm:affiliation>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chow, Pierce Kh" sort="Chow, Pierce Kh" uniqKey="Chow P" first="Pierce Kh" last="Chow">Pierce Kh Chow</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>Division of Surgical Oncology, National Cancer Centre Singapore, Singapore</wicri:regionArea>
<wicri:noRegion>Singapore</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vilgrain, Valerie" sort="Vilgrain, Valerie" uniqKey="Vilgrain V" first="Valérie" last="Vilgrain">Valérie Vilgrain</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Radiology, Assistance Publique, Hôpitaux de Paris, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiology, Assistance Publique, Hôpitaux de Paris, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">JMIR research protocols</title>
<idno type="ISSN">1929-0748</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Untreated advanced hepatocellular carcinoma (HCC) has an overall poor prognosis. Currently there are 2 ongoing prospective randomized controlled trials that are evaluating the efficacy and safety of sorafenib and selective internal radiation therapy (SIRT) with yttrium-90 resin microspheres in patients with advanced HCC. The SorAfenib versus Radioembolisation in Advanced Hepatocellular carcinoma (SARAH; 459 patients) trial is being performed in Europe and the SIRt VErsus SorafeNIB (SIRveNIB; 360 patients) trial in the Asia Pacific region. Prospectively combining the results, these trials will not only allow for increased precision to estimate efficacy (in terms of survival), but will also provide increased statistical power for subgroup analyses.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>France</li>
<li>Singapour</li>
</country>
<region><li>Nouvelle-Galles du Sud</li>
<li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
<li>Sydney</li>
</settlement>
<orgName><li>Université de Sydney</li>
</orgName>
</list>
<tree><country name="Australie"><noRegion><name sortKey="Gebski, Val" sort="Gebski, Val" uniqKey="Gebski V" first="Val" last="Gebski">Val Gebski</name>
</noRegion>
<name sortKey="Gibbs, Emma" sort="Gibbs, Emma" uniqKey="Gibbs E" first="Emma" last="Gibbs">Emma Gibbs</name>
</country>
<country name="Singapour"><noRegion><name sortKey="Gandhi, Mihir" sort="Gandhi, Mihir" uniqKey="Gandhi M" first="Mihir" last="Gandhi">Mihir Gandhi</name>
</noRegion>
<name sortKey="Chow, Pierce Kh" sort="Chow, Pierce Kh" uniqKey="Chow P" first="Pierce Kh" last="Chow">Pierce Kh Chow</name>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Chatellier, Gilles" sort="Chatellier, Gilles" uniqKey="Chatellier G" first="Gilles" last="Chatellier">Gilles Chatellier</name>
</region>
<name sortKey="Dinut, Aurelia" sort="Dinut, Aurelia" uniqKey="Dinut A" first="Aurelia" last="Dinut">Aurelia Dinut</name>
<name sortKey="Pereira, Helena" sort="Pereira, Helena" uniqKey="Pereira H" first="Helena" last="Pereira">Helena Pereira</name>
<name sortKey="Vilgrain, Valerie" sort="Vilgrain, Valerie" uniqKey="Vilgrain V" first="Valérie" last="Vilgrain">Valérie Vilgrain</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000086 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000086 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28202430
   |texte=   VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28202430" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials.

VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.